State Street Corporation 13D and 13G filings for Sorrento Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-10 11:21 am Sale | 2023-02-28 | 13G | Sorrento Therapeutics, Inc. SRNE | STATE STREET CORP STT | 156,800 0.030% | -50,480,771 (-99.69%) | Filing |
| 2023-02-09 3:48 pm Purchase | 2022-12-31 | 13G | Sorrento Therapeutics, Inc. SRNE | STATE STREET CORP STT | 50,637,571 10.730% | 10,976,472 (+27.68%) | Filing |
| 2022-07-11 11:38 am Purchase | 2022-06-30 | 13G | Sorrento Therapeutics, Inc. SRNE | STATE STREET CORP STT | 39,661,099 10.200% | 39,661,099 (New Position) | Filing |